Fluticasone propionate stability
Pro Research Analysisby 
Searched over 200M research papers
Fluticasone Propionate Stability: Formulation and Analytical Method Keywords
Improved Stability in Fluticasone Propionate Sprays
Recent advancements in fluticasone propionate spray formulations have shown that adding disodium edetate to traditional preservatives like benzalkonium chloride and phenylethyl alcohol significantly enhances the stability of the product. This combination helps maintain the spray mode, droplet distribution, and pH value over long-term storage, even without the need for additional pH-adjusting agents. The preparation remains stable, with minimal changes in its physical and chemical properties during storage, which is a notable improvement over traditional formulations .
Analytical Methods for Stability and Impurity Profiling
Validated stability-indicating analytical methods are crucial for monitoring fluticasone propionate in both active pharmaceutical ingredients (API) and finished dosage forms. High-performance thin-layer chromatography (HPTLC) and high-performance liquid chromatography (HPLC) methods have been developed and validated according to ICH guidelines. These methods are sensitive, accurate, and robust, capable of detecting and quantifying fluticasone propionate and its impurities even under stress conditions such as acidic, basic, oxidative, and thermal environments. Notably, significant degradation was observed under basic and acidic conditions, but not under thermal or oxidative stress, indicating the drug's relative stability to heat and oxidation 24.
Nanoparticle and Nanocarrier Formulations for Enhanced Stability
Formulating fluticasone propionate in solid lipid nanoparticles (SLNs) and lipid nanocapsules (LNCs) has been shown to improve both the drug's stability and its therapeutic efficacy. SLNs demonstrated good physical stability, with optimal particle size and zeta potential, and maintained their integrity during storage and use. Similarly, LNCs provided high encapsulation efficiency and maintained drug stability during nebulization, with no leakage or phase separation observed. These advanced delivery systems protect fluticasone propionate from environmental stressors and enhance its stability in various pharmaceutical applications 56.
In Situ Gelling Nanosuspensions for Nasal Delivery
In situ gelling nanosuspensions, which incorporate fluticasone propionate nanocrystals into polymeric gels, have also been developed for nasal delivery. These formulations exhibit improved drug release profiles, enhanced mucoadhesive properties, and excellent physico-chemical stability. The optimized systems ensure efficient nasal deposition and maintain stability, making them promising for safe and effective corticosteroid delivery .
Conclusion
Fluticasone propionate stability can be significantly improved through innovative formulation strategies, such as the use of combined stabilizing agents, advanced analytical methods for impurity profiling, and novel drug delivery systems like nanoparticles and in situ gelling nanosuspensions. These approaches ensure the drug remains effective and safe throughout its shelf life and during administration, supporting its continued use in respiratory and dermatological therapies 1245+2 MORE.
Sources and full results
Most relevant research papers on this topic
Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study
Adding fluticasone propionate twice weekly to emollient maintenance treatment significantly reduces the risk of relapse in patients with atopic dermatitis.
Fluticasone propionate–loaded solid lipid nanoparticles with augmented anti-inflammatory activity: optimisation, characterisation and pharmacodynamic evaluation on rats
Optimised fluticasone propionate-loaded solid lipid nanoparticles effectively reduce inflammation and show potential as an efficient tool for treating inflammatory skin diseases.
In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery.
In situ gelling nanosuspension is an advanced platform for fluticasone propionate nasal delivery, achieving optimal nasal deposition and safety, with 51.8% of dose deposited in the middle meatus for treatment of rhinosinusitis and nasal polyposis.
DOI